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Abstract 
Background and objectives: The Korean National Health Insurance Service (NHIS) database has been widely used 
for cardiovascular research. We validated the primary diagnostic codes of major clinical outcomes, including acute 
myocardial infarction (AMI), gastrointestinal bleeding (GIB), stroke, and intracranial hemorrhage (ICH) used for Korea 
NHIS claims.
Subjects and methods: From 2016 to 2017, 800 patients with primary diagnostic codes of AMI, GIB, stroke, or ICH 
at discharge were randomly selected from a single tertiary medical center in Korea (200 patients per each diagnosis). 
The positive predictive value (PPV), sensitivity, and specificity of the primary diagnostic codes were calculated using 
hospital medical record review as the gold standard. Further improvement in the diagnostic validity of the codes was 
assessed by combining clinical information such as duration of hospitalization, blood transfusion, brain imaging stud‑
ies, or prescription records of antithrombotic agents.
Results: Among 200 patients with AMI as the primary discharge diagnosis, 184 patients were clinically confirmed 
(PPV of 92.0%). For GIB, 184 (92.0%) patients with the primary discharge diagnosis were verified to have true GIB 
events, showing PPV of 92%. For stroke, 181 (90.5%) patients were clinically confirmed with true stroke events. For 
ICH, 143 (71.5%) patients were verified to be true ICH events. In stroke and ICH, the PPV and specificity improved after 
combining with the hospitalization duration, imaging studies, and prescription of antithrombotic agents.
Conclusions: For major clinical outcomes in the NHIS database, the primary diagnostic codes showed favorable reli‑
ability. For stroke and ICH, considerations of relevant clinical information could improve the accuracy of diagnosis.
Keywords: Myocardial infarction, Gastrointestinal bleeding, Stroke, Intracranial hemorrhages, Validity
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Introduction
Nationwide population-based analysis is now widely 
used to evaluate the prevalence of a specific disease and 
to discover the relationship between new risk factors 
and clinical outcomes [1, 2]. Moreover, as the analysis 
targets the whole population, this approach could give 
a real-world evidence, especially in patients who were 
not included in well-designed randomized controlled 
trials [3]. The National Health Insurance Service (NHIS) 
is a single-insurer system, which covers the whole popu-
lation of Korea  [4, 5]. The NHIS provides various medi-
cal information of the  Korean population over the past 
decades, including inpatient and outpatient records of 
diagnostic codes, procedures, examinations including 
imaging studies, medication prescriptions, and demo-
graphic information of patients. Recently, public access 
to the NHIS database has been available, which enabled 
many researchers to apply the population-based analysis 
in various study fields including epidemiology, econom-
ics, environmental policy and industry and public health 
and medicine [6–10]. In a population-based analysis, 
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diagnostic codes of the disease based on the International 
Classification of Diseases (ICD) code is used to identify 
clinical outcomes. However, in Korea, as the record of the 
diagnosis is cumulatively stored in the claims database, it 
is hard to differentiate true clinical events from previous 
records based on diagnostic codes. In this regard, most 
of the population-based studies in Korea had focused on 
primary prevention of the disease by excluding patients 
with previous diagnosis of the study outcome [6–10]. 
Previously, several studies had attempted to evaluate the 
validity of primary diagnostic codes in nationwide claims 
based on its higher association with true clinical events 
[11, 12]. However, there is a paucity of reports assessing 
the validity of the primary diagnostic codes in the NHIS 
database in Korea. Therefore, we aimed to validate the 
primary diagnostic codes at discharge in patients with 
major clinical outcomes including acute myocardial 
infarction (AMI), gastrointestinal bleeding (GIB), stroke, 
and intracranial hemorrhage (ICH).
Methods
Data source and study population
From the database of a single tertiary medical center in 
Korea (Seoul National University Hospital), patients 
who had primary diagnostic codes of AMI, GIB, stroke, 
or ICH at discharge from 2016 to 2017 were randomly 
selected (200 patients for each diagnosis). The diagnos-
tic codes of clinical outcomes were based on the Inter-
national Classification of Diseases code, tenth version 
(ICD-10 code, Table 1). The study protocol of the current 
study was approved waived for informed consent by the 
Seoul National University Hospital Institutional Review 
Board (No. 1805-133-948).
The validation of diagnosis for acute myocardial infarction 
and gastrointestinal bleeding
Among the 200 patients with primary discharge diagnos-
tic codes of AMI (ICD-10 code I21, I22) at discharge, true 
AMI events were identified based on the universal defini-
tion of AMI [13] by reviewing medical records including 
discharge records electrocardiograms, laboratory results 
such as cardiac enzymes, procedure records including 
percutaneous coronary intervention or coronary artery 
bypass graft surgery and prescriptions of medications 
(antiplatelet agents, statin or beta-blockers).
Primary discharge diagnostic codes representing upper 
and lower GIB were selected (Table  1). Patients with a 
true GIB event were identified through reviewing dis-
charge records, procedure records including gastroduo-
denoscopy or colonoscopy with endoscopic hemostasis 
or transcatheter arterial embolization, the initial serum 
hemoglobin level or the existence of blood transfusions of 
red blood cells. The true GIB events were defined as fol-
lowing: (1) definite visual detection of bleeding or clearly 
documented medical records of bleeding described by 
physicians; or (2) identification of bleeding sources by 
endoscopic or imaging studies, which were accordant 
to the previous study [14]. Moreover, the history of red 
blood cell (RBC) transfusion was used as the inclusion 
criteria to evaluate improvement in diagnostic accuracy.
The validation of diagnosis for stroke and intracranial 
hemorrhage
True cases of stroke were verified based on medical 
records, including discharge records, a duration of hos-
pitalization, brain imaging studies including a computed 
tomography (CT) scan or a magnetic resonance imag-
ing (MRI), and prescription records of antithrombotic 
agents. From the previous studies, the median duration 
of hospital stay was reported for 7.4  days (interquartile 
range 5.1–11.7) [15]. Therefore, the  duration of hos-
pitalization more than 3  days was analyzed whether it 
improves the accuracy of diagnosis. For antithrombotic 
agents, any prescription record of the medication at dis-
charge was considered for inclusion criteria in patients 
with stroke diagnoses.
For the confirmation of patients with true ICH 
events, we reviewed medical records, including dis-
charge records, a duration of hospitalization, brain CT 
or MRI, and prescription records of antithrombotic 
agents. To improve the accuracy, we added no pre-
scriptions of antithrombotic agents at discharge as one 
of the diagnostic criteria of ICH.
Table 1 Diagnostic codes (ICD-10) for clinical outcomes
Clinical outcomes Diagnostic codes
Myocardial infarction I21, I22
Gastrointestinal bleeding K22.6, K25.0, K25.2, K25.4, K25.6, K26.0, K26.2, K26.4, K26.6, K27.0, K27.2, 
K27.4, K27.6, K28.0, K28.2, K28.4, K28.6, K29.0, K62.5, K92.0, K92.1, 
K92.2
Ischemic stroke I63, I64
Intracranial hemorrhage I60, I61, I62
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Statistical analysis
The two investigators (JSP and KSI) reviewed the med-
ical records independently to discriminate true clinical 
outcomes. In the cases with discordance, agreement 
by discussion was used to make a final decision. Posi-
tive predictive value (PPV), sensitivity, and specificity 
were evaluated for each diagnostic code of the clinical 
outcomes. The PPV was calculated using the following 
formula: the numbers of patients with the true event 
of study outcome confirmed by medical record review/
the total numbers of patients with ICD-10 codes × 100 
(%). The final diagnoses for false positive cases in each 
clinical outcome were summarized to overview the 
factors affecting the accuracy. Statistical analyses were 
performed using SPSS, version 21.0 (SPSS Inc., Win-
dows, Chicago, IL, USA).
Results
Acute myocardial infarction
The validation result of AMI is given in Table 2. Among 
the 200 cases, 184 cases (92%) were identified to have true 
AMI events who had admitted to the hospital for. The 
rest of 16 (8.0%) cases were those who were admitted for 
follow-up elective coronary angiography (n = 11, 5.5%), 
presented with angina (n = 2, 1.0%) or had previous his-
tory of AMI (n = 3, 1.5%) (Additional file 1: Table S1). The 
PPV of the diagnostic code was 92.0%.
Gastrointestinal bleeding
Among the 200 randomly selected cases, 184 patients 
(92%) were confirmed to be true GIB events (Table  3). 
The major proportion of false cases were those who had 
a previous history of GIB (n = 9, 4.5%) followed by those 
with no clinical evidence of GIB (n = 4, 2.0%) and bleed-
ing event other than GI tract (3, 1.5%) (Additional file 1: 
Table  S1). When RBC transfusion was combined with 
diagnostic code, 44 cases (22.0%), with 41 true events, 
were excluded, and there was no improvement in PPV 
(91.7%) with sensitivity and specificity of 77.7% and 
18.8%, respectively.
Stroke
Various combinations of diagnostic criteria for stroke are 
given in Table 4. The combination of primary diagnostic 
code with brain imaging studies showed PPV and sensi-
tivity of 92.2% and 91.2%, respectively. By combining pre-
scription records of antithrombotic agents with primary 
diagnostic codes, PPV and sensitivity were 93.4% and 
93.4%, respectively. Among various inclusion criteria, the 
highest PPV, sensitivity, and specificity were achieved by 
combining primary diagnostic code with hospitalization 
over 3  days and prescription records of antithrombotic 
therapy (PPV 94.3%, sensitivity 90.1%, and specificity 
47.4%).
Table 2 Validation of  diagnostic codes for  myocardial 
infarction
PPV positive predictive value
Total True False PPV (%)
Hospitalization + primary diag‑
nostic code





Table 3 Validation of diagnostic codes for gastrointestinal bleeding
PPV positive predictive value, RBC red blood cell
GI bleeding Total True False PPV (%) Sensitivity (%) Specificity (%)
Hospitalization + primary diagnostic code 200 (100) 184 (92.0) 16 (8.0) 92.0
Hospitalization + primary diagnostic 
code + RBC transfusion
156 (100) 143 (91.7) 13 (8.3) 91.7 77.7 18.8
Table 4 Validation of diagnostic codes for stroke
PPV positive predictive value
a Brain imaging studies including a computed tomography (CT) scan or a magnetic resonance imaging (MRI)
b At least ≥ 1 prescription of antithrombotic agents at discharge
Ischemic stroke Total True False PPV (%) Sensitivity (%) Specificity (%)
Hospitalization + primary diagnostic code 200 (100) 181 (90.5) 19 (9.5) 90.5 – –
Hospitalization + primary diagnostic code + imaging  diagnosisa 179 (100) 165 (92.2) 14 (7.8) 92.2 91.2 26.3
Hospitalization + primary diagnostic code + prescriptionb 181 (100) 169 (93.4) 12 (6.6) 93.4 93.4 36.8
Hospitalization (over 3 days) + primary diagnostic code + imaging 
diagnosis
170 (100) 157 (92.4) 13 (7.6) 92.4 86.7 31.6
Hospitalization (over 3 days) + primary diagnostic code + prescription 173 (100) 163 (94.2) 10 (5.8) 94.2 90.1 47.4
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Intracranial hemorrhage
Table 5 shows the validation results of various inclusion 
criteria for ICH events. The combination of primary 
diagnostic code with hospitalization and brain imaging 
studies showed PPV, sensitivity, and specificity of 81.4%, 
95.1%, and 45.6%, respectively. When combining the 
primary diagnostic code with hospitalization and pre-
scription of antithrombotic therapy, we found that PPV, 
sensitivity, and specificity were 72.1%, 90.2%, and 12.3%, 
respectively. By considering the condition for the dura-
tion of hospitalization (over 3 days), PPV and specificity 
showed mild improvement in both criteria.
Discussion
We have validated that the primary diagnostic codes at 
discharge of major clinical outcomes comprising AMI, 
GIB, stroke, and ICH were favorable and reliable, which 
could be used in nationwide population-based studies 
based on the NHIS database.
Validation of primary diagnostic code in identifying acute 
myocardial infarction
In our study results, a  reliable diagnosis for AMI was 
shown with PPV 92% based on primary diagnosis codes 
at discharge. The PPV of AMI in our result is compara-
ble to those previously reported, which ranges from 93 
to 96.9%, though the diagnostic codes in these studies 
were based on ICD-9 [11, 12]. Cheng et al. had reviewed 
medical records of 281 patients with the  primary diag-
nostic code of AMI and showed PPV of 93% [11]. Also, 
they compared multiple inclusion criteria by combining 
medical records of antithrombotic agents or procedures 
for coronary revascularization. The highest PPV (95%) 
was found in that comprising primary diagnosis for AMI 
and percutaneous coronary intervention, although it 
showed the lowest sensitivity (62%). In the current study, 
we did not include information of coronary revasculari-
zation, such as percutaneous coronary intervention or 
bypass surgery. As a  substantial proportion of patients 
with AMI would not require coronary revascularization 
[16], considering procedure information with diagnostic 
code in defining AMI may increase false negative rates. 
Petersen et al. had reported PPV of 96.9% of AMI among 
4712 patients with primary diagnostic code for AMI at 
admission [12]. In his report, of 147 false positive cases, 
54% (n = 82) of them were those only with a  previous 
history of AMI, which were similar to our results. Pre-
viously, Kimm et  al. had reported validation study for 
AMI using diagnostic codes based on ICD-10, which 
showed somewhat a lower diagnostic accuracy of 71.4% 
compared to our result  [17]. In this study, the authors 
selected patients with any diagnostic code of I21 (not I22) 
from 1994 to 2007 and investigated medical informa-
tion of the patients by survey with questionnaires from 
multiple study centers. Therefore, those with insufficient 
survey records would be excluded, and higher numbers 
of false positive cases could be included compared to pre-
vious studies using primary diagnostic code, which may 
result in the relatively lower rate of PPV. However, due 
to development in electronic medical record system and 
high sensitivity diagnostic modalities, the accuracy of the 
diagnostic codes for AMI has been improved recently, 
which is supported by the recent study from the same 
research group reporting improved PPV of 85.6% among 
164 patients from 2009 to 2011  [18].
Validation in gastrointestinal bleeding
In our study results, the  primary discharge diagnostic 
code showed PPV of 82% for true GIB event. Cunning-
ham et  al. had reported a  validation of bleeding events 
among 186 warfarin users by using primary diagnostic 
code during hospitalization [19]. Of the 120 patients who 
had a primary diagnostic code for GI bleeding, PPV was 
85.8%. And, 73.8% of those patients were definite bleed-
ing events. Another study validated bleeding codes com-
prising intracranial, gastrointestinal, genitourinary, and 
respiratory bleeding from ICD-9 in 361 warfarin users 
reporting PPV of 91%  [14]. In this study, patients who 
were hospitalized due to the bleeding event, accompa-
nied with a decrease in hemoglobin level > 2  g/L or had 
Table 5 Validation of diagnostic codes for intracranial hemorrhage
PPV positive predictive value
a Brain imaging studies including a computed tomography (CT) scan or a magnetic resonance imaging (MRI)
b No prescription of any antithrombotic agents at discharge
Intracranial hemorrhage Total True False PPV (%) Sensitivity (%) Specificity (%)
Hospitalization + primary diagnostic code 200 (100) 143 (71.5) 57 (28.5) 71.5 – –
Hospitalization + primary diagnostic code + imaging  diagnosisa 167 (100) 136 (81.4) 31 (18.6) 81.4 95.1 45.6
Hospitalization + primary diagnostic code + prescriptionb 179 (100) 129 (72.1) 50 (27.9) 72.1 90.2 12.3
Hospitalization (over 3 days) + primary diagnostic code + imaging 
diagnosis
153 (100) 127 (83.0) 26 (17.0) 83.0 88.8 54.4
Hospitalization (over 3 days) + primary diagnostic code + prescription 142 (100) 118 (83.1) 24 (16.9) 83.1 82.5 57.9
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undergone ≥ 2 units of RBC transfusion were defined as 
those with major bleeding events, which showed PPV 
of 87%. Although hemoglobin level is not available in 
the NHIS database, history of RBC transfusion could be 
analyzed in those with GIB events. However, we found 
that combining information of RBC transfusion with 
primary diagnosis at discharge did not improve the PPV 
and resulted in lower sensitivity. Although RBC transfu-
sion related to bleeding events was considered as a major 
or severe bleeding condition in the  previous classifica-
tion system [20], it could exclude patients with evident 
GIB events but without indication for blood transfusion. 
In our result, after combining RBC transfusion with pri-
mary diagnostic code and hospitalization, 44 patients 
were excluded whom 93.2% of them were true events. 
Also, as most of the false positive cases had RBC trans-
fusion based on a low level of hemoglobin without clear 
gastrointestinal bleeding focus, information on RBC 
transfusion cannot discriminate these patients. How-
ever, considering that all patients with GIB in our study 
had hospital admission, the primary diagnostic code of 
GIB with hospitalization might be sufficient to identify 
patients with true major GIB.
Validation of diagnostic code in stroke and intracranial 
hemorrhage
Previous number of studies had validated the diagnos-
tic codes for stroke, and ICH with a wide range of PPV 
depends on different criteria for outcome confirma-
tion [21, 22]. Golomb et  al. had validated ICD-9 codes 
of stroke among 663 children from 1999 to 2004 with 
outcome confirmation based on radiologic evidence of 
stroke. In this report, compared to diagnostic code in 
any position, those in the primary position showed better 
PPV (88% to 92% for code 436 and 37% to 53% for code 
342). Park et  al. had reported a validation study among 
626 patients with a primary diagnosis for cerebrovascular 
disease (ICD-10, I60–I68) in medical claims from 1993 
to 1997 [23]. The accuracy rate of the diagnostic code for 
stroke was 83.4% for I63 and 71.4% for I64–I68. Although 
the medical information of the patients was retrieved by 
trained record administrator using survey methods from 
study centers, 18.2% (n = 114) of patients were excluded 
for analysis due to incomplete or unavailable medical 
information, which may result in relatively lower accu-
racy than our result.
In the current study, we tried to improve the accuracy 
of the primary diagnostic code by combining relevant 
clinical information. In both stroke and ICH, a  combi-
nation of primary discharge diagnostic code, hospitali-
zation at least 3 days, and conditions for prescription of 
antithrombotic agents showed the highest PPV. However, 
the specificity was low ranged less than 60% regardless 
of combination with brain imaging studies or conditions 
for prescription of antithrombotic agents (26.3% to 47.4% 
for stroke and 12.3% to 57.9% for ICH). As for the false 
positive cases in stroke event, most of them were those 
with a previous history of stroke or suspected for symp-
toms which show no evidence of stroke in clinical or any 
diagnostic modalities. Majority of false positive cases in 
ICH were those with previous history of ICH and those 
admitted for unrelated medical issues such as a routine 
follow-up examination for cerebral angiography. Previ-
ously, Park et al. had investigated factors associated with 
the inaccuracy of diagnostic codes in medical insurance 
claims [23]. Among them, the most frequent reason of 
the inaccuracy was to meet review criteria of medical 
insurance benefits (n = 45 of 85 cases, 52.9%) followed 
by incorrect coding habits (n = 13, 15.3%) and diagnostic 
error (n = 9, 10.6%), which would explain the relatively 
higher false positive rate in diagnostic codes for stroke 
and ICH.
Limitations
Several limitations of our study must be clarified. First, 
as for MI validation, we did not include the prescription 
records in validation compared to the previous report 
[11]. However, we concluded that it is sufficient to dis-
criminate the true MI events based on primary diagnosis, 
and there could be false negative cases excluded by apply-
ing strict inclusion criteria. Second, as for GIB, labora-
tory data of hemoglobin level or hemodynamic condition 
of the patient such as systolic blood pressure or pulse rate 
could not be considered as inclusion criteria which were 
not available in the  NHIS database. Third, the specific-
ity of the inclusion criteria in GIB, stroke, and ICH was 
relatively low. For GIB and stroke, the primary diagnos-
tic code demonstrated favorable performance in PPV 
(92.0% and 90.5% for GIB and stroke, respectively), and 
the number of false positive cases was small (16 and 19 
for GIB and stroke, respectively). As most of those cases 
were included to the additional criteria (i.e., RBC trans-
fusion, brain imaging studies, or prescription records of 
antithrombotic therapy) irrelevant to the true diagnosis, 
the specificity was low. For ICH, however, the primary 
diagnostic code showed moderate accuracy (PPV 71.5%). 
Therefore, the additional inclusion criteria improved 
both PPV and specificity. These results suggest that pri-
mary diagnostic code would be sufficient to identify true 
patients correctly, and supplementary clinical informa-
tion could be considered in case higher PPV is pursued. 
Fourth, this study was performed in a  tertiary medical 
center, and the definition was not validated in primary 
and secondary hospitals, so further study including pri-
mary and secondary hospital would be needed. Finally, 
this study could not evaluate the patients with false 
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negative. We only analyzed the patients with the primary 
diagnostic code of clinical outcomes, but it is also impor-
tant to assess the patients without primary diagnostic 
code but actual clinical events.
Conclusion
Primary discharge diagnostic code showed favorable 
reliability in AMI and GIB which showed high PPV in 
those with primary diagnostic code at discharge and 
hospitalization. Stroke and ICH showed the highest 
accuracy in a combination of primary diagnostic code, 
hospitalization, and prescription. Primary discharge 
diagnostic code of AMI, GIB, stroke, and ICH could be 
used for outcome study using the NHIS database.
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